October 5, 2026
Shionogi to Acquire IntraBio for  Billion




The Japanese drugmaker said IntraBio’s expertise would strengthen capabilities across its rare disease pipeline.

About The Author

Leave a Reply

Your email address will not be published. Required fields are marked *